Application 206886
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AFIRMELLE | ETHINYL ESTRADIOL; LEVONORGESTREL | TABLET;ORAL-28 | 0.02MG;0.1MG | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50102-220 | Aubra EQ | Levonorgestrel and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-220 | Aubra EQ | Levonorgestrel and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-220 | Aubra EQ | Levonorgestrel and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-220 | Aubra EQ | Levonorgestrel and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 50102-220 | Aubra EQ | Levonorgestrel and Ethinyl Estradiol | Afaxys Pharma, LLC | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-849 | Afirmelle | Levonorgestrel and Ethinyl Estradiol | Aurobindo Pharma Limited | ANDA | Current |